<?xml version="1.0" encoding="UTF-8"?>
<p>EMA assessment of the available literature suggests that ginsenoside metabolites contribute substantially to the pharmacological effects of ginseng.
 <xref rid="med21743-bib-0002" ref-type="ref">
  <sup>2</sup>
 </xref> The metabolites are well distributed to most of the tissues.
 <xref rid="med21743-bib-0593" ref-type="ref">
  <sup>593</sup>
 </xref> It was concluded that metabolites of ginsenosides produced by gut microbiota might be more biologically active than their precursors.
 <xref rid="med21743-bib-0002" ref-type="ref">
  <sup>2</sup>
 </xref> The results of recent studies
 <xref rid="med21743-bib-0624" ref-type="ref">
  <sup>624</sup>
 </xref>, 
 <xref rid="med21743-bib-0625" ref-type="ref">
  <sup>625</sup>
 </xref> are in line with this conclusion: the ginseng preparation with a higher content of rare ginsenosides was more active in its ability to prevent symptoms of stress such as fatigue, impaired memory, reduced concentration, and attention deficit related to daily work in healthy subjects
 <xref rid="med21743-bib-0624" ref-type="ref">
  <sup>624</sup>
 </xref> as well as enhanced long‚Äêterm potentiation in rat hippocampal slices.
 <xref rid="med21743-bib-0625" ref-type="ref">
  <sup>625</sup>
 </xref> An active ginseng metabolite may differ in distribution and clearance from its parent compound, and the parent compound and its metabolite may be bioactive by similar or different mechanisms.
 <xref rid="med21743-bib-0342" ref-type="ref">
  <sup>342</sup>
 </xref>
</p>
